Continuing Medical Education Conference Coverage CROI 2017

CROI Main Banner

About the Program

Program Overview

The ARV Therapies and Therapeutic Strategies program is a comprehensive, independent review of the 24th Conference on Retroviruses and Opportunistic Infections (CROI 2017). This program consists of three components: (1) CME Internet Symposium: CROI 2017 Expert Review: an Internet symposium featuring an overview and discussion of key presentations and posters, selected by the expert faculty discussants; (2) Comprehensive Expert Review and Discussion of Key Presentations: an on-line, in-depth review of 8 of the key poster/presentations reviewed in the Internet symposium; and (3) Rapid-Fire Review of CROI 2017: a podcast that provides a brief, audio summary of the most essential data presented at the conference.

This program is produced by the Postgraduate Institute for Medicine and ViralEd, Inc. It is not a session created by or presented at CROI 2017 and it is not sanctioned by the organizers of CROI 2017.

Media: Internet

Back to Top

Target Audience

This activity has been designed to meet the educational needs of physicians, physician assistants, advanced practice nurses and other health care professionals involved in the care of patients with HIV infection.

Back to Top

Learning Objectives

After completing these activities, participants should be better able to:

  • Use data reported at CROI 2017 for counseling, testing and antiretroviral treatment to prevent HIV infection, especially in underserved communities
  • Use in a clinical setting findings from key studies on HIV/AIDS diagnosis, management, and treatment presented at CROI 2017
  • Employ strategies based on studies and data presented at CROI 2017 for helping HIV-positive patients in medically underserved communities link to and stay in appropriate and effective HIV care
  • Discuss with patients and colleagues the studies and data on therapies for HIV/AIDS presented at CROI 2017 and use that discussion to decide on appropriate planning of therapy for patients with HIV/AIDS

Faculty

José Arribas, MD
Research Director (AIDS and Infectious Diseases)
Hospital de La Paz
Madrid, Spain 

Richard A. Elion, MD
Professor of Medicine
Associate Professor of Clinical Medicine
George Washington University Medical Center
Washington, DC

Ian Frank, MD
Professor of Medicine
Director, Clinical Therapeutics Program
Penn Center for AIDS Research
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania

Graeme Moyle, MD, MB, BS
Associate Director of HIV Research
Chelsea & Westminster Hospital
London, United Kingdom 

Jürgen Rockstroh, MD
Professor
University of Bonn
Bonn, Germany

Paul Sax, MD
Clinical Director
Division of Infectious Diseases
Brigham and Women's Hospital
Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Renslow Sherer, MD
Professor of Medicine
Section of Infectious Diseases and Global Health
University of Chicago
Chicago, Illinois 

Back to Top

Physician Continuing Medical Education

 This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and ViralEd, Inc. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

On-Demand Internet Symposium

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Comprehensive Expert Review and Discussion of Key Presentations

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

There are 8 posters and presentations available for a total of 2.00 possible credit hours.

Rapid-Fire Review of CROI 2017

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Back to Top

Instructions for Participation and Credit

On-Demand Internet Symposium

There are no fees for participating and receiving CME credit for this activity. During the period, February 28, 2017 through February 28, 2018, participants must read the learning objectives and faculty disclosures and study the educational activity.

PIM supports Green CME by offering your Request for Credit online. If you wish to received acknowledgment of completing this activity, please complete the post-test and evaluation on www.cmeuniveristy.com. On the navigation menu, click on "Find Post-test/Evaluation by Course" and search by course ID 12237.  Upon registering and successfully completing the post-test with a score of 70% or better and the activity evaluation, your certificate will be made available immediately.  Processing credit requests online will reduce the amount of paper used by nearly 100,000 sheets per year.

Comprehensive Expert Review and Discussion of Key Presentations

There are no fees for participating and receiving CME credit for this activity. During the period, February 24, 2017 through February 24, 2018, participants must read the learning objectives and faculty disclosures and study the educational activity.

PIM supports Green CME by offering your Request for Credit online. If you wish to received acknowledgment of completing this activity, please complete the post-test and evaluation on www.cmeuniveristy.com. On the navigation menu, click on "Find Post-test/Evaluation by Course" and search by course ID 12239.  Upon registering and successfully completing the post-test with a score of 70% or better and the activity evaluation, your certificate will be made available immediately.  Processing credit requests online will reduce the amount of paper used by nearly 100,000 sheets per year.

Rapid-Fire Review from CROI 2017 (Audio Podcast)

There are no fees for participating and receiving CME credit for this activity. During the period, February 23, 2017 through February 23, 2018, participants must read the learning objectives and faculty disclosures and study the educational activity.

PIM supports Green CME by offering your Request for Credit online. If you wish to received acknowledgment of completing this activity, please complete the post-test and evaluation on www.cmeuniveristy.com. On the navigation menu, click on "Find Post-test/Evaluation by Course" and search by course ID 12238.  Upon registering and successfully completing the post-test with a score of 70% or better and the activity evaluation, your certificate will be made available immediately.  Processing credit requests online will reduce the amount of paper used by nearly 100,000 sheets per year. 

 

Disclosure of Conflicts of Interest

The Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity. 

Back to Top

Jose Arribas, MD

  • Consulting Fees: ViiV, Tibotec, Janssen, Abbvie, BMS, Gilead, MSD

Richard Elion, MD

  • Consulting Fees: Gilead, ViiV
  • Fees for Non-CME/CE Services Received Directly from a Commercial Interest: Gilead, Merck, Janssen

Ian Frank, MD

  • Consulting Fees: Gilead, ViiV
  • Contracted Research: GSK, Bavarian Nordic
  • Other (expert testimony): Janssen

Graeme Moyle, MD

  • Consulting Fees: Merck, BMS, Teva
  • Fees for Non-CME/CE Services: Merck, BMS, Gilead Sciences, Janssen, ViiV Healthcare
  • Ownership Interest: Tobira
  • Other: Board Membership - Tobira

Jürgen Rockstroh, MD

  • Consulting Fees: Abbvie, Bionor, BMS, Gilead, Janssen, Merck, ViiV
  • Fees for Non-CME/CE Services: Abbvie, BMS, Gilead, Janssen, Merck, ViiV
  • Contracted Research: Gilead

Paul Sax, MD

  • Consulting Fees: AbbVie, BMS, Gilead, GSK/ViiV, Merck, Janssen
  • Contracted Research: BMS, Gilead, GSK/ViiV, Merck

Renslow Sherer, MD

  • Consulting Fees: Gilead
Back to Top

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.  

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners.  Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Back to Top

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities. 

Back to Top

    PIM_small

 

This activity is supported by an independent educational grant from Gilead Sciences Medical Affairs.

This coverage is not sanctioned by the conference organizers and is not an official part of the conference proceedings.

 

Back to Top

 

     

Prepare to print

Share this page:

Get link code to this page     


Back to Top